{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:07:51Z","timestamp":1787735271260,"version":"build-2784847793"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","award":["2017.0303"],"award-info":[{"award-number":["2017.0303"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The abnormalities in human metabolism have been implicated in the progression of several complex human diseases, including certain cancers. Hence, deciphering the underlying molecular mechanisms associated with metabolic reprogramming in a disease state can greatly assist in elucidating the disease aetiology. An invaluable tool for establishing connections between global metabolic reprogramming and disease development is the genome-scale metabolic model (GEM). Here, we review recent work on the reconstruction of cell\/tissue-type and cancer-specific GEMs and their use in identifying metabolic changes occurring in response to liver disease development, stratification of the heterogeneous disease population and discovery of novel drug targets and biomarkers. We also discuss how GEMs can be integrated with other biological networks for generating more comprehensive cell\/tissue models. In addition, we review the various biological network analyses that have been employed for the development of efficient treatment strategies. Finally, we present three case studies in which independent studies converged on conclusions underlying liver disease.<\/jats:p>","DOI":"10.1093\/bib\/bbaa002","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T12:16:27Z","timestamp":1579695387000},"page":"1751-1766","source":"Crossref","is-referenced-by-count":8,"title":["Addressing the heterogeneity in liver diseases using biological networks"],"prefix":"10.1093","volume":"22","author":[{"given":"Simon","family":"Lam","sequence":"first","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, SE1 9RT, United Kingdom; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-17121, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Doran","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, SE1 9RT, United Kingdom; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-17121, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Hilal","family":"Yuksel","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, SE1 9RT, United Kingdom; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-17121, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Altay","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, SE1 9RT, United Kingdom; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-17121, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Turkez","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, SE1 9RT, United Kingdom; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-17121, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, SE1 9RT, United Kingdom; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-17121, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Boren","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, SE1 9RT, United Kingdom; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-17121, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Uhlen","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, SE1 9RT, United Kingdom; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-17121, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Mardinoglu","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, SE1 9RT, United Kingdom; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-17121, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"2021032314292748600_ref1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12072-019-09959-y","article-title":"Hepatology through the crystal ball","volume":"13","author":"Williams","year":"2019","journal-title":"Hepatol Int"},{"key":"2021032314292748600_ref2","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","article-title":"Treatment options for alcoholic and non-alcoholic fatty liver disease: a review","volume":"23","author":"Singh","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2021032314292748600_ref3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41575-018-0007-8","article-title":"Systems biology in hepatology: approaches and applications","volume":"15","author":"Mardinoglu","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2021032314292748600_ref4","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"2021032314292748600_ref5","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.celrep.2016.04.056","article-title":"Glycosaminoglycan profiling in patients\u2019 plasma and urine predicts the occurrence of metastatic clear cell renal cell carcinoma","volume":"15","author":"Gatto","year":"2016","journal-title":"Cell Rep"},{"key":"2021032314292748600_ref6","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.celrep.2015.10.045","article-title":"Stratification of hepatocellular carcinoma patients based on acetate utilization","volume":"13","author":"Bj\u00f6rnson","year":"2015","journal-title":"Cell Rep"},{"key":"2021032314292748600_ref7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.15252\/msb.20145307","article-title":"Modeling cancer metabolism on a genome scale","volume":"11","author":"Yizhak","year":"2015","journal-title":"Mol Syst Biol"},{"key":"2021032314292748600_ref8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/msb.145122","article-title":"Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling","volume":"10","author":"Agren","year":"2014","journal-title":"Mol Syst Biol"},{"key":"2021032314292748600_ref9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.molmed.2017.08.003","article-title":"Precision oncology: the road ahead","volume":"23","author":"Senft","year":"2017","journal-title":"Trends Mol Med"},{"key":"2021032314292748600_ref10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2796.2003.01242.x","article-title":"Obesity - is it a genetic disorder?","volume":"254","author":"Loos","year":"2003","journal-title":"J Intern Med"},{"key":"2021032314292748600_ref11","doi-asserted-by":"crossref","first-page":"916","DOI":"10.15252\/msb.20167422","article-title":"Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD","volume":"13","author":"Mardinoglu","year":"2017","journal-title":"Mol Syst Biol"},{"key":"2021032314292748600_ref12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/nu11071578","article-title":"The potential use of metabolic cofactors in treatment of NAFLD","volume":"11","author":"Mardinoglu","year":"2019","journal-title":"Nutrients"},{"key":"2021032314292748600_ref13","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/ncomms4083","article-title":"Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease","volume":"5","author":"Mardinoglu","year":"2014","journal-title":"Nat Commun"},{"key":"2021032314292748600_ref14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cmet.2018.01.005","article-title":"An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic Steatosis in humans","volume":"27","author":"Mardinoglu","year":"2018","journal-title":"Cell Metab"},{"key":"2021032314292748600_ref15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cels.2017.12.013","article-title":"Integrative personal Omics profiles during periods of weight gain and loss","volume":"6","author":"Piening","year":"2018","journal-title":"Cell Syst"},{"key":"2021032314292748600_ref16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.15252\/msb.20156487","article-title":"The gut microbiota modulates host amino acid and glutathione metabolism in mice","volume":"11","author":"Mardinoglu","year":"2015","journal-title":"Mol Syst Biol"},{"key":"2021032314292748600_ref17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fgene.2014.00086","article-title":"Elucidating the interactions between the human gut microbiota and its host through metabolic modeling","volume":"5","author":"Shoaie","year":"2014","journal-title":"Front Genet"},{"key":"2021032314292748600_ref18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/joim.12508","article-title":"The gut microbiota and metabolic disease: current understanding and future perspectives","volume":"280","author":"Arora","year":"2016","journal-title":"J Intern Med"},{"key":"2021032314292748600_ref19","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021032314292748600_ref20","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.2337\/db14-1916","article-title":"Dietary polyphenols promote growth of the gut bacterium akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome","volume":"64","author":"Roopchand","year":"2015","journal-title":"Diabetes"},{"issue":"29","key":"2021032314292748600_ref21","article-title":"Disturbed vitamin A metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"10","author":"Saeed","year":"2018","journal-title":"Nutrients"},{"key":"2021032314292748600_ref22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"2021032314292748600_ref23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/antiox7010012","article-title":"Vitamin E as a treatment for nonalcoholic fatty liver disease: reality or myth?","volume":"7","author":"El Hadi","year":"2018","journal-title":"Antioxidants"},{"key":"2021032314292748600_ref24","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1053\/gast.2002.35952","article-title":"Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice","volume":"123","author":"Demeilliers","year":"2002","journal-title":"Gastroenterology"},{"key":"2021032314292748600_ref25","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/hep.24279","article-title":"The contribution of endoplasmic reticulum stress to liver diseases","volume":"53","author":"Dara","year":"2011","journal-title":"Hepatology"},{"key":"2021032314292748600_ref26","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents the tonic randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA - JAMA"},{"key":"2021032314292748600_ref27","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"2021032314292748600_ref28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clinre.2011.10.011","article-title":"Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results","volume":"36","author":"Pietu","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2021032314292748600_ref29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"2021032314292748600_ref30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2036.2006.02885.x","article-title":"Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study","volume":"23","author":"Capanni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2021032314292748600_ref31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/09637486.2010.487480","article-title":"Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study","volume":"61","author":"Sofi","year":"2010","journal-title":"Int J Food Sci Nutr"},{"key":"2021032314292748600_ref32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2007.10.003","article-title":"Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease","volume":"40","author":"Spadaro","year":"2008","journal-title":"Dig Liver Dis"},{"key":"2021032314292748600_ref33","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.3748\/wjg.14.6395","article-title":"Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia","volume":"14","author":"Zhu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2021032314292748600_ref34","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/ajg.2009.719","article-title":"L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitisa randomized and controlled clinical trial","volume":"105","author":"Malaguarnera","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2021032314292748600_ref35","first-page":"12","article-title":"N-acetylcysteine improves liver function in patients with non-alcoholic fatty liver disease","volume":"10","author":"Khoshbaten","year":"2010","journal-title":"Hepat Mon"},{"key":"2021032314292748600_ref36","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0016-5085(03)00323-8","article-title":"Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial","volume":"124","author":"Marchesini","year":"2003","journal-title":"Gastroenterology"},{"key":"2021032314292748600_ref37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1542-3565(05)00017-0","article-title":"Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis","volume":"3","author":"Muto","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021032314292748600_ref38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/antiox4010204","article-title":"Silymarin as a natural antioxidant: an overview of the current evidence and perspectives","volume":"4","author":"Surai","year":"2015","journal-title":"Antioxidants"},{"key":"2021032314292748600_ref39","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.freeradbiomed.2012.02.008","article-title":"Silybin combined with phosphatidylcholine and vitamin e in patients with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"52","author":"Loguercio","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"2021032314292748600_ref40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2796.2011.02493.x","article-title":"Systems medicine and metabolic modelling","volume":"271","author":"Mardinoglu","year":"2012","journal-title":"J Intern Med"},{"key":"2021032314292748600_ref41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.copbio.2014.12.013","article-title":"New paradigms for metabolic modeling of human cells","volume":"34","author":"Mardinoglu","year":"2015","journal-title":"Curr Opin Biotechnol"},{"key":"2021032314292748600_ref42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.compbiomed.2017.07.005","article-title":"Computational modelling of genome-scale metabolic networks and its application to CHO cell cultures","volume":"88","author":"Rejc","year":"2017","journal-title":"Comput Biol Med"},{"key":"2021032314292748600_ref43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/bioinformatics\/btq702","article-title":"Functional integration of a metabolic network model and expression data without arbitrary thresholding","volume":"27","author":"Jensen","year":"2011","journal-title":"Bioinformatics"},{"key":"2021032314292748600_ref44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1752-0509-5-147","article-title":"TIGER: toolbox for integrating genome-scale metabolic models, expression data, and transcriptional regulatory networks","volume":"5","author":"Jensen","year":"2011","journal-title":"BMC Syst Biol"},{"key":"2021032314292748600_ref45","first-page":"663096","article-title":"RMetD2: a tool for integration of relative transcriptomics data into genome-scale metabolic models","author":"Zhang","year":"2019","journal-title":"bioRxiv"},{"key":"2021032314292748600_ref46","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nbt.4072","article-title":"Recon3D enables a three-dimensional view of gene variation in human metabolism","volume":"36","author":"Brunk","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2021032314292748600_ref47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymben.2019.01.001","article-title":"Pyruvate kinase L\/R is a regulator of lipid metabolism and mitochondrial function","volume":"52","author":"Liu","year":"2019","journal-title":"Metab Eng"},{"key":"2021032314292748600_ref48","doi-asserted-by":"crossref","first-page":"e1006760","DOI":"10.1371\/journal.pcbi.1006760","article-title":"Investigating the deregulation of metabolic tasks via minimum network enrichment analysis (MiNEA) as applied to nonalcoholic fatty liver disease using mouse and human omics data","volume":"15","author":"Pandey","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"2021032314292748600_ref49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cmet.2016.05.026","article-title":"Integrated network analysis reveals an association between plasma mannose levels and insulin resistance","volume":"24","author":"Lee","year":"2016","journal-title":"Cell Metab"},{"key":"2021032314292748600_ref50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2017.07.006","article-title":"Plasma mannose levels are associated with incident type 2 diabetes and cardiovascular disease","volume":"26","author":"Mardinoglu","year":"2017","journal-title":"Cell Metab"},{"key":"2021032314292748600_ref51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.15252\/msb.20177703","article-title":"Network analyses identify liver-specific targets for treating liver diseases","volume":"13","author":"Lee","year":"2017","journal-title":"Mol Syst Biol"},{"key":"2021032314292748600_ref52","doi-asserted-by":"crossref","first-page":"D595","DOI":"10.1093\/nar\/gkx994","article-title":"TCSBN: a database of tissue and cancer specific biological networks","volume":"46","author":"Lee","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021032314292748600_ref53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/joim.12384","article-title":"The Swedish CArdioPulmonary BioImage study: objectives and design","volume":"278","author":"Bergstr\u00f6m","year":"2015","journal-title":"J Intern Med"},{"key":"2021032314292748600_ref54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nbt.3870","article-title":"A wellness study of 108 individuals using personal, dense, dynamic data clouds","volume":"35","author":"Price","year":"2017","journal-title":"Nat Biotechnol"},{"key":"2021032314292748600_ref55","first-page":"662502","article-title":"MOBN: an interactive database of multi-omics biological networks","author":"Zhang","year":"2019","journal-title":"bioRxiv"},{"key":"2021032314292748600_ref56","doi-asserted-by":"crossref","first-page":"E11874","DOI":"10.1073\/pnas.1807305115","article-title":"Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes","volume":"115","author":"Bidkhori","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021032314292748600_ref57","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/ncomms3447","article-title":"Exact controllability of complex networks","volume":"4","author":"Yuan","year":"2013","journal-title":"Nat Commun"},{"key":"2021032314292748600_ref58","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1073\/pnas.1603992113","article-title":"Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets","volume":"113","author":"Vinayagam","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021032314292748600_ref59","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fphys.2018.00916","article-title":"Metabolic network-based identification and prioritization of anticancer targets based on expression data in hepatocellular carcinoma","volume":"9","author":"Bidkhori","year":"2018","journal-title":"Front Physiol"},{"key":"2021032314292748600_ref60","first-page":"2014","article-title":"The role of hypoxia inducible factor-1 in hepatocellular carcinoma","volume":"409272","author":"Luo","year":"2014","journal-title":"Biomed Res Int"},{"key":"2021032314292748600_ref61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbrc.2013.06.021","article-title":"Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma","volume":"436","author":"Dai","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"2021032314292748600_ref62","article-title":"Discovery of functional alternatively spliced PKM transcripts in human cancers","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"2021032314292748600_ref63","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.15252\/embr.201643300","article-title":"PKM2, cancer metabolism, and the road ahead","volume":"17","author":"Dayton","year":"2016","journal-title":"EMBO Rep"},{"key":"2021032314292748600_ref64","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat Genet"},{"key":"2021032314292748600_ref65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/abbs\/gms106","article-title":"Dual roles of PKM2 in cancer metabolism","volume":"45","author":"Wu","year":"2013","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2021032314292748600_ref66","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1016\/S0021-9258(18)55378-3","article-title":"In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate","volume":"266","author":"Ashizawa","year":"1991","journal-title":"J Biol Chem"},{"key":"2021032314292748600_ref67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","article-title":"Pyruvate kinase: function regulation and role in cancer","volume":"43","author":"Israelsen","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"2021032314292748600_ref68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semradonc.2018.10.003","article-title":"Targeting cancer stem cell redox metabolism to enhance therapy responses","volume":"29","author":"Luo","year":"2019","journal-title":"Semin Radiat Oncol"},{"key":"2021032314292748600_ref69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tibs.2019.01.001","article-title":"Targeting metabolic\u2013redox circuits for cancer therapy","volume":"44","author":"Wang","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"2021032314292748600_ref70","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ebiom.2018.12.057","article-title":"Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis","volume":"40","author":"Benfeitas","year":"2019","journal-title":"EBioMedicine"},{"key":"2021032314292748600_ref71","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2021032314292748600_ref72","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"2021032314292748600_ref73","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"2021032314292748600_ref74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3892\/mmr.2012.1201","article-title":"Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC","volume":"7","author":"Tanaka","year":"2013","journal-title":"Mol Med Rep"},{"key":"2021032314292748600_ref75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41540-018-0070-3","article-title":"Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease","volume":"4","author":"Maldonado","year":"2018","journal-title":"NPJ Syst Biol Appl"},{"key":"2021032314292748600_ref76","doi-asserted-by":"crossref","first-page":"ii121","DOI":"10.1093\/ndt\/gfw330","article-title":"The ascending rank of chronic kidney disease in the global burden of disease study","volume":"32","author":"Jager","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2021032314292748600_ref77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/chd.12383","article-title":"The global burden of cardiovascular disease","volume":"11","author":"Moodie","year":"2016","journal-title":"Congenit Heart Dis"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/1751\/36654285\/bbaa002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/1751\/36654285\/bbaa002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T14:55:49Z","timestamp":1616511349000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/22\/2\/1751\/5810888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,3,23]]},"published-print":{"date-parts":[[2021,3,22]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaa002","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2020,3,23]]}}}